Chorioamnionitis: Clinical Trials

2 trials for Chorioamnionitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 22Completed 2

Follow Chorioamnionitis: new trials by email Literature Review of Chorioamnionitis trials Research Report on Chorioamnionitis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety of N-acetylcysteine in Maternal Chorioamnionitis (NAC in Chorio)
N-acetylcysteine, Control - Chorioamnionitis, Brain Injury
Phase 1 / Phase 2CompletedMedical University of South Carolina462008-08-012021-04-12
N-acetylcysteine in Intra-amniotic Infection/Inflammation
amniocentesis, N-acetylcysteine or placebo - Labor, Premature, Preterm Premature Rupture of the Membranes
Phase 1 / Phase 2CompletedOhio State University682006-10-012018-10-10

Narrower conditions

Brain Injuries (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Obstetric Labor, Premature (1)  ·  Preterm Premature Rupture of the Membranes (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Fetal Diseases (2)  ·  Fetal Membranes, Premature Rupture (2)  ·  Obstetric Labor Complications (2)  ·  Placenta Diseases (2)  ·  Pregnancy Complications (2)  ·  Urogenital Diseases (2)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Craniocerebral Trauma (1)  ·  Nervous System Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Trauma, Nervous System (1)

Interventions

Acetylcysteine (2)  ·  Amniocentesis (1)  ·  Sodium Chloride (1)

Sponsors

Medical University of South Carolina (1)  ·  Ohio State University (1)

Countries

United States (2)

Top investigators

Catalin S Buhimschi, MD, MBA (1)  ·  Dorothea D. Jenkins, MD (1)  ·  Eugene Chang, MD (1)

Results publications

PMID 25064164, PMID 26545726

NIH funding

R01NS052448 (1)